EBR Systems, Inc. (EBRCZ) stock: key figures, P/E, revenue and dividend
Health Care · United States
EBR Systems, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 1.62 m USD |
| Gross profit | 490,000.00 USD |
| Operating income | -46.09 m USD |
| EBIT | -45.82 m USD |
| Net income | -48.76 m USD |
| Diluted EPS – continuing operations | -0.12 USD |
Full history since 2022, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About EBR Systems, Inc.
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.
More stocks
- Corbus Pharmaceuticals Holdings, Inc. (CRBP)
- Venu Holding Corp (VENU)
- Hoffmann Green Cement Technologies (ALHGR.PA)
- Adtraction Group AB (ADTR.ST)
- Fuzetec Technology Co Ltd (6642.TWO)
- Stabilis Solutions, Inc. (SLNG)
- Zevia PBC (ZVIA)
- AIAI Holdings Corporation Class A Common Stock (AIAI)
- Futebol Clube do Porto - Futebol S.A.D. (FCP.LS)
- U.S. GoldMining Inc. (USGO)
- Smothong Group Public Company Limited (SMO.BK)
- PT Buana Artha Anugerah Tbk (STAR.JK)
Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.